chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ringing in his ears; felt like he was having a stroke; dizzy; sweating like crazy; nauseated; vomiting; tired; sore; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing in his ears), FEELING ABNORMAL (felt like he was having a stroke), DIZZINESS (dizzy), HYPERHIDROSIS (sweating like crazy) and NAUSEA (nauseated) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062G20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced TINNITUS (ringing in his ears), FEELING ABNORMAL (felt like he was having a stroke), DIZZINESS (dizzy), HYPERHIDROSIS (sweating like crazy), NAUSEA (nauseated), VOMITING (vomiting), FATIGUE (tired) and MYALGIA (sore). At the time of the report, TINNITUS (ringing in his ears), FEELING ABNORMAL (felt like he was having a stroke), DIZZINESS (dizzy), HYPERHIDROSIS (sweating like crazy), NAUSEA (nauseated), VOMITING (vomiting), FATIGUE (tired) and MYALGIA (sore) outcome was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
No symptoms or adverse effects reported; Nurse reports 8 patients received unspecified dose of PROQUAD that was improperly stored; This spontaneous report was received from a registered nurse, referring to patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history and previous drugs reactions or allergies were not provided.  On 02-OCT-2019, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (concentration, number of administered dose, vaccination scheme frequency, route and anatomical location of vaccination were not reported; reported lot number S012530 and expiration date 20-OCT-2020) as prophylaxis. The sterile diluent (manufacturer unknown) used was properly stored.  According to the reporter, the temperature excursion was -12.8 degrees Celsius for a time frame of two hours and 38 minutes on an unspecified date (product storage error), with multiple previous temperature excursion of, the worst temperature/ was -9.8 degrees Celsius for about 112 minutes; which was detected by a digital data logger.  This is one of eight reports received from the same reporter.; Sender's Comments:  US-009507513-2005USA009891:
TDap was given to term neonate instead of Hep B vaccine. Increased frequency of vital sign monitoring. No physical reaction occurred. Vital signs remained stable and he got his normal Hep B vaccine the next day with out difficulty.
headache; inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939904) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered). On 31-Oct-2021, the patient experienced HEADACHE (headache). On 30-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered) had resolved. At the time of the report, HEADACHE (headache) outcome was unknown.            Patient received Johnson & Johnson as her first dose. No concomitant medications was reported. no treatment was reported.
Tested positive for COVID; A little bit of fever last night and then today or this morning, she has a higher fever around 101; Daughter is 2 and a half years old; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A child female patient of age 2 and a half year-old received BNT162b2 (BNT162B2), as dose 1, single (Lot number: FT9142) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (non-serious), outcome "unknown", described as "Tested positive for COVID"; PYREXIA (non-serious), outcome "unknown", described as "A little bit of fever last night and then today or this morning, she has a higher fever around 101"; PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious), outcome "unknown", described as "Daughter is 2 and a half years old". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Transferring agent stated, I have a caller on the other line. His daughter received, his daughter was 2 and a half years old (not confirmed and clarified) and just received the first shot last night and she had a fever, a little bit of fever/ low grade fever last night and then today or this morning, she had a higher fever around 101. Caller wanted to know if the vaccine can cause a false positive result. On confirming if the reporter only wants to report or needs any information transferring agent stated, he would like to report that adverse event as well as his daughter tested positive as well for COVID. So he wants to know if the vaccine can cause the COVID-19. On paraphrasing the concern reporter stated, that was correct and she also, we just tested her and she did come up positive for the test. So I am just curious if that is possibly positive from the vaccine shot or it is actually a Covid test.  No follow-up attempts are possible. No further information is expected.
Vision impairment two days after shot. Wavy, blurry light at edges of vision, like a kaleidoscope. Neck pain, headache. Not yet treated, seeing doctor tomorrow.
This spontaneous case reported by a healthcare professional, describes the occurrence of pneumococcal immunisation (took pneumonia shot 2 days after the Moderna vaccine) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 013M20A) for COVID-19 immunization. No medical history reported. On Feb 6, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 8, 2021, patient experienced pneumococcal immunisation (took pneumonia shot 2 days after the Moderna vaccine). At the time of the report, pneumococcal immunisation (took pneumonia shot 2 days after the Moderna vaccine): unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments, concomitant product use or treatment information.
Information has been received from a nurse practitioner concerning a 63 year old white female with no known drug allergies and history of shingles who in 25-JAN-2007 at approximately 10:00 AM was vaccinated IM with a dose of Zostavax (Oka/Merck) (lot #652925/0621F).  Concomitant therapy included losartan potassium (MSD), sertraline HCl (Zoloft), atenolol (Atenolol MF) and aspirin.  In January 2007, the patient developed from shoulder to elbow redness, hardness, warm to touch and tender to touch on the arm where vaccination was given.  The patient had symptoms for 2 weeks and at the time the patient had recovered.  Unspecified medical attention was sought.  A product quality complaint was not involved.  Additional information has been received from a nurse practitioner who stated that the patient had extreme local reaction on arm.  The patient's arm was swollen and was fiery red and painful.  The patient was treated with cool compress.  No diagnostic laboratory tests were undertaken.  At the time of report the patient had recovered.  No further information is expected.
Severe pain, swelling, warmth to injection site onset a few hours after vaccine administered. Presented to office following day. Applied ice pack and administered MOTRIN 800 mg PO.
Heart flutters, palpitations (rapid heart beat feeling), weird taste sensation. All when laying down in bed.
Patient was accidentally, applied 10 doses of Pfizer COV Bivalent Vaccine. Patient is asymptomatic. Physical exdlorition is unremarkable. Mother and father were informed.
at noon the day after my vaccine, i started with chills, body aches and fever that reached 103 at tmax, was taking tyl and ibuprofen at recommended amounts and hydrating. the feve persisted, i ended up with high pulse rate in the 120-130 range, chest pain and shortness of breath. it hurt to breathe, similar to the feeling i had when i got covid. i went to the ER for care at 9 pm
This case was reported by a consumer via call center representative and described the occurrence of ophthalmic herpes zoster in a adult patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX and the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant), shingles and product supply issue. On an unknown date, the outcome of the ophthalmic herpes zoster, shingles and product supply issue were unknown. It was unknown if the reporter considered the ophthalmic herpes zoster and shingles to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication. The patient received SHINGRIX just over 6 months before the date of reporting. As the providers had trouble getting more of the vaccine the patient's insurance could not indeed cover the vaccine. The patient could not find the vaccine and wanted it soon. The patient experienced shingles that attacked the upper right quadrant of head (including the right eye) at the same time the patient underwent cataract surgery on the right eye and it almost blinded. The patient very much wanted to receive the 2nd dose of SHINGRIX and realized it was the same as the initial one. The patient asked for help and made a habit of calling everywhere on a regular basis and had done all one could do.
This spontaneous report was received from a physician regarding his 15 year old son via company representative. The patient's concurrent conditions, concomitant medications, medical history, past drugs, allergies and reactions were unknown. On an unknown date, the patient was vaccinated with GARDASIL 9 (dosage schedule was not reported) (strength, lot#, batch and expiry date were unknown) via intramuscular route for prophylaxis. It was reported that few months ago, the patient passed out (loss of consciousness) shortly afterwards and showed seizure like activity (seizure like phenomena). It was reported that, patient had sought medical attention and was in physician's office when event occurred. The outcome of loss of consciousness and seizure like phenomena was reported as recovered. Causality of the suspect therapy GARDASIL 9 with respect to events was not reported by the reporter. No PQC(product quality complaint) was involved. Upon internal review, the events loss of consciousness and seizure like phenomena were considered as medically significant.
Puffy, itchy red rash, starting on forearms, moving to hands, thighs, torso - appearing for an hour or so, disappearing for a while and reappearing in the same place at times, intensity varying.
Headache for 2 days starting the night of the day she received vaccine. Then 2 days later developed burning sensation in the skin of one leg. This started at night on 1/18/21 and progressed to both legs and arms on 1/19/21. No associated weakness.
chills, severe shaking that started at 8:30pm and lasted about three hours.  Body aches and joint pain that started at 8:30 pm and lasted about six ours.  Severe headache that started about 7am on 1/31/2021 (the day after my vaccination) and lasted about 12 hours.  Fatigue that lasted until 1/31/2021 around 7pm.
pt developed arm numbing for a few hours, went to hospital and got checked.  everything was fine.  numbing got better in a few hours
Patient noticed significant swelling within about 2 hours after the injection. She reported it being warm to the touch but not particularly painful. Now two days later the swelling has subsided but is still noticeable.
Metallic taste; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (Metallic taste). At the time of the report, DYSGEUSIA (Metallic taste) had not resolved.            Concomitant product use was not provided by the reporter. Treatment information was not provided.    This case was linked to MOD-2021-081339 (Patient Link).
09/17/22 presents to ED for "shortness of breath, cough". PMHx of "CAD, NSTEMI, CHF on brilenta, asthma".
Family was waiting in exam room after vaccine administration as per our standard office policy. Approximately 2-3 minutes after vaccine administration, patient broke out in diffuse urticaria with lesions coalescing and covering most of her anterior and posterior torso with extension to her proximal extremities, neck and face. She also had facial erythema and edema, including her eyelids, lips and ears. No tongue swelling. She was coughing repeatedly and scratching at her ears and neck. She was alert and active. No cyanosis. Her lungs were clear with good aeration throughout, no increased work of breathing, and no wheezing on initial auscultation as well as on serial re-evaluations performed by me prior to EMS arrival. No vomiting. She was immediately given IM epinephrine (0.15 mg) followed by IM BENADRYL (15 mg). I prepare mother for need for transport to pediatric emergency room for ongoing treatment if needed and for ongoing close monitoring. I spoke with pediatric emergency room attending at hospital by phone to give report as well as with EMS to arrange for transportation to hospital. Patient was also given IM DECADRON (7 mg) after discussion with Dr. EMS report given upon their arrival. Patient's cough had resolved within approximately 10-15 minutes from onset of this anaphylactic reaction. She remained alert and active throughout this time period. Her hives were improving though not resolved upon discharge with EMS. Her facial erythema and edema were still present upon discharge with EMS. Mother and I had previously discussed a catch-up schedule for patient's immunizations (to include HepB#2, IPV#2 and Varicella#1 in 4 weeks, then HepB#3, IPV#3, and HepA#1 in 8 weeks) prior to this anaphylactic reaction. Mother was informed that any future vaccinations will now be deferred until further evaluation by a pediatric allergist. Mother verbalized understanding and agreement. Will file VAERS report. Addendum: I called and spoke with mother on 4/14/15 at 11:20 AM for update. She was pleased to report that patient was doing very well. She said patient was given a dose of ZANTAC in ER and observed for approximately 3 hrs before discharge home. She said all of her hives and swelling had resolved prior to discharge home. She never developed any wheezing or need for breathing treatments. She has been asymptomatic since. She also informed me that patient's fraternal twin who was also seen by me for his 2 yr WCC and received the same catch-up vaccinations at the same time as his sister ended up breaking out in some hives while with a sitter during the time period she was in the ER with patient. The sitter gave him a dose of oral BENADRYL and his hives eventually resolved that same evening and have not returned. He had no other symptoms except for the hives per mother.
It gave me the flu twice; Initial information received on 29-Oct-2020 regarding an unsolicited valid non-serious social media case received from a consumer.  This case involves a patient who got the flu twice (influenza), while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were unknown.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, patient who got the flu twice (influenza) (Unknown latency) following the administration of INFLUENZA VACCINE.  Final diagnosis was influenza.  Relevant laboratory data was not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was reported as Unknown.    There will be no information available on the batch number for this case.
anaphylactic shock; difficulty breathing; faced was paralyzed; rash on arms and chest; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of ANAPHYLACTIC REACTION (anaphylactic shock), DYSPNOEA (difficulty breathing) and FACIAL PARALYSIS (faced was paralyzed) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced ANAPHYLACTIC REACTION (anaphylactic shock) (seriousness criterion life threatening), DYSPNOEA (difficulty breathing) (seriousness criterion medically significant), FACIAL PARALYSIS (faced was paralyzed) (seriousness criterion medically significant) and RASH (rash on arms and chest). At the time of the report, ANAPHYLACTIC REACTION (anaphylactic shock), DYSPNOEA (difficulty breathing), FACIAL PARALYSIS (faced was paralyzed) and RASH (rash on arms and chest) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication included epinephrine injection.  Company comment: based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   This case was linked to MODERNATX, INC.-MOD-2021-081859 (E2B Linked Report).; Sender's Comments: based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded. MODERNATX, INC.-MOD-2021-081859:Crossed linked
An hour after vaccine patient states arm started hurting. Then it went numb. Patient went to ER thinking she had a heart attack. After relevant tests they decided she actually tore her rotator cuff. Unknown if any follow up tests were actually done.
Chronic hives.  They started the next evening and got steadily worse, constantly moving patches about every 3-4 hrs.  First round lasted 3 days, about 2 weeks later again for 3 more days.  I had to take an OTC allergy medication and a steroid shot to calm them down enough.  I have reoccurrences about every 2-3 weeks that last about 24hrs, small patches that still move around every so often.  They mostly focus in areas when my clothes rub or when I get overly hot (after a workout).  I still take 1 allergy pill when I notice them starting to appear, it usually eases up within a few hours.  Every once in awhile it will last longer even after the allergy medication.  Only 1 occasion when they lasted over 24hrs after the first two bouts.
8"  7 3/4" size red swollen, Hot and very tight Right arm from shoulder to elbow. Sent child to urgent clinic. Keflex 250 Qid X 10 days
neck pain; high fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck pain), CHILLS (chills) and PYREXIA (high fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, LOSARTAN, METFORMIN and VITAMIN D3 for an unknown indication.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced CHILLS (chills). On 01-Mar-2021, the patient experienced NECK PAIN (neck pain) and PYREXIA (high fever). The patient was treated with HYDROCODONE BITARTRATE, PARACETAMOL (VICODIN) at a dose of UNK dosage form; IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of UNK dosage form and PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 23-Feb-2021, CHILLS (chills) had resolved. On 07-Mar-2021, NECK PAIN (neck pain) had resolved. At the time of the report, PYREXIA (high fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, SARS-CoV-2 antibody test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
face was starting to itchy right after getting the vaccine, ear also started to itch. she also had hives the next day but went away after taking benadyl.
An hour after treatment the arm I got the shot in was almost unusable. This began to extent to my upper back and neck. Started getting really bad heart burn that lasted about 1 full day. 4 days later, I have a constant dull pain radiating from the middle of my chest to my left armpit. Kind of feels like the middle of my chest is bruised. I have not felt right since the shot and kind of scared to go back for the second.
Right side arm, hand, leg and feet were numb. Tingling pins and needles, that did not go away for over 24 hours.
This case was reported by a healthcare professional (nurse) and described the occurrence of pain during injection in an unspecified number of subjects of unspecified ages and gender who were vaccinated with CERVARIX (GlaxoSmithKline). On unspecified dates the subjects received unspecified doses of CERVARIX (unknown) mixed with Lidocaine and experienced inappropriate preparation of medication. During vaccination with CERVARIX, the subjects experienced pain during injection. The nurse reported that it was brought to the attention of patient safety at the outpatient clinics that a physician was mixing Lidocaine with CERVARIX to reduce pain during administration (pain during injection). The nurse inquired if there were any contraindications to administering the vaccine with another medication. At the time of the reporting the outcome of the pain during injection was unspecified.
Headache, Myalgia, Rash, redness, soreness, fatigue Narrative: